Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 12-2017 | 12-2013 | |
| Sales | 0 | 0 | 0 | 0 | 113,505 |
| Operating Expenses | 6,422 | 2,714 | 0 | 0 | 0 |
| Operating Income | -6,422 | -2,714 | N/A | N/A | N/A |
| Interest Expense | 122 | 122 | 0 | 0 | 13,425 |
| Other Income | 253 | 21 | 0 | 0 | 42,559 |
| Pre-tax Income | -6,291 | -2,815 | 0 | 0 | 29,134 |
| Income Tax | N/A | N/A | N/A | N/A | 6,980 |
| Net Income Continuous | -6,291 | -2,815 | N/A | N/A | 22,154 |
| Net Income | $-6,291 | $-2,815 | $N/A | $N/A | $22,154 |
| EPS Basic Total Ops | -5.48 | -2.51 | N/A | N/A | 0.35 |
| EPS Basic Continuous Ops | -5.48 | -2.51 | N/A | N/A | 0.36 |
| EPS Diluted Total Ops | -5.48 | -2.51 | N/A | N/A | 0.35 |
| EPS Diluted Continuous Ops | -5.48 | -2.51 | N/A | N/A | 0.35 |
| EBITDA(a) | $-6,446 | $-2,654 | $N/A | $N/A | $N/A |